Clinical Trial Update: Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the acute treatment efficacy of diclofenac potassium and rimegepant for migraine has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• DICLOFENAC POTASSIUM (diclofenac potassium)
• Rimegepant (rimegepant)

Snippet

Sponsor: Danish Headache Center | Conditions: Migraine With Aura, Migraine Without Aura | Phase 4 | Status: TERMINATED